Mitotane (dichlorodifenyldichloroethane, DDD) it is a polychlorinated compound derivative of dichlorodiphenyltrichloroethane (DDT), prescribed in inoperable adrenocortical renal carcinoma and Cushing’s syndrome [1,2]. DDD and its principal metabolite, dichlorodiphenylethene (DDE), can accumulate in fat tissues [3] and plasma concentrations are more related with clinical improvement, than those of dichlorodiphenylacetate (DDA), another metabolite of DDD. HPLC methods constitute a valid alternative to gas chromatography, and plasma concentrations of 14–20 mg/L are considered therapeutic concentrations. The stationary phase was represented by a Higgins Analytical C18 5 μm column (250mmx4.6 mm), at 35 oC. Mobile phase was made by H2O/ac...
The metabolism of “C-labeled 1-(o-chlorophenyl)- 1-(p-chlorophenyl)-2.2-dichloroethane (o.p’-DDD) in...
Polybrominated diphenyl ethers (PBDEs) are flame retardants widely used in electronic and domestic g...
CONTEXT: In patients with adrenocortical carcinoma (ACC) mitotane activity has been suggested to...
Introduction Mitotane (dichlorodifenyldichloroethane, DDD) it is a polychlorinated compound deriva...
NTRODUCTION Mitotane (dichlorodifenyldichloroethane, DDD) it is a polychlorinated compound derivativ...
Mitotane (DDD) is prescribed in adrenocortical renal carcinoma. Its principal metabolite, dichlorodi...
Mitotane (o,p'-DDD or (1,1-dichloro-2-[o-chlorophenyl]-2-[p-chlorophenyl]ethane, DDD) is the drug of...
A simple and reliable new HPLC method with UV detection has been developed and validated for simulta...
A new C18 reversed-phase column and UV HPLC method for the detection of mitotane, its principal meta...
A rapid micromethod for 50-μl samples is described for the analysis in plasma of mitotane (o,p′-DDD)...
Mitotane ($o,p\sp\prime$-DDD; 2,2 bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane) has been us...
Mitotane ($o,p'$-DDD; 1- (2-chlorophenyl) -1- (4-chlorophenyl) -2,2-dichloroethane) has been used in...
Mitotane is the reference drug for the adrenocortical carcinoma treatment; its pharmacological activ...
Mitotane (o,p'-DDD) can be used for the treatment of various adrenocortical diseases such as Cushing...
Mitotane, 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane (o,p'-DDD), a structural analog o...
The metabolism of “C-labeled 1-(o-chlorophenyl)- 1-(p-chlorophenyl)-2.2-dichloroethane (o.p’-DDD) in...
Polybrominated diphenyl ethers (PBDEs) are flame retardants widely used in electronic and domestic g...
CONTEXT: In patients with adrenocortical carcinoma (ACC) mitotane activity has been suggested to...
Introduction Mitotane (dichlorodifenyldichloroethane, DDD) it is a polychlorinated compound deriva...
NTRODUCTION Mitotane (dichlorodifenyldichloroethane, DDD) it is a polychlorinated compound derivativ...
Mitotane (DDD) is prescribed in adrenocortical renal carcinoma. Its principal metabolite, dichlorodi...
Mitotane (o,p'-DDD or (1,1-dichloro-2-[o-chlorophenyl]-2-[p-chlorophenyl]ethane, DDD) is the drug of...
A simple and reliable new HPLC method with UV detection has been developed and validated for simulta...
A new C18 reversed-phase column and UV HPLC method for the detection of mitotane, its principal meta...
A rapid micromethod for 50-μl samples is described for the analysis in plasma of mitotane (o,p′-DDD)...
Mitotane ($o,p\sp\prime$-DDD; 2,2 bis(2-chlorophenyl-4-chlorophenyl)-1,1-dichloroethane) has been us...
Mitotane ($o,p'$-DDD; 1- (2-chlorophenyl) -1- (4-chlorophenyl) -2,2-dichloroethane) has been used in...
Mitotane is the reference drug for the adrenocortical carcinoma treatment; its pharmacological activ...
Mitotane (o,p'-DDD) can be used for the treatment of various adrenocortical diseases such as Cushing...
Mitotane, 1-(2-chlorophenyl)-1-(4-chlorophenyl)-2,2-dichloroethane (o,p'-DDD), a structural analog o...
The metabolism of “C-labeled 1-(o-chlorophenyl)- 1-(p-chlorophenyl)-2.2-dichloroethane (o.p’-DDD) in...
Polybrominated diphenyl ethers (PBDEs) are flame retardants widely used in electronic and domestic g...
CONTEXT: In patients with adrenocortical carcinoma (ACC) mitotane activity has been suggested to...